Market revenue in 2024 | USD 141.5 million |
Market revenue in 2030 | USD 260.4 million |
Growth rate | 10.9% (CAGR from 2025 to 2030) |
Largest segment | Dystonia |
Fastest growing segment | Epilepsy |
Historical data covered | 2018 - 2023 |
Base year for estimation | 2024 |
Forecast period covered | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Pain Management, Epilepsy, Essential Tremor, Obsessive Compulsive Disorder (OCD), Parkinsons Disease, Depression, Dystonia |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Nexstim Oyj Registered Shs Reg S, LivaNova PLC, NeuroPace Inc |
Dystonia was the largest segment with a revenue share of 75.69% in 2024. Horizon Databook has segmented the Latin America deep brain stimulation devices market based on pain management, epilepsy, essential tremor, obsessive compulsive disorder (ocd), parkinsons disease, depression, dystonia covering the revenue growth of each sub-segment from 2018 to 2030.
Major countries contributing to the growth of Latin America deep brain stimulation devices market are Brazil and Mexico. Growing healthcare expenditure coupled with rising penetration of health insurance in most of the Latin American countries is providing considerable growth opportunities to players operating in the global market.
Moreover, several health agreements exist between U.S. medical centers and private hospitals in Brazil and Argentina. These agreements have increased awareness about new technologies in the market, boosting the adoption of deep brain stimulation systems.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account